Numolux Group, the South African partner of China’s Sinovac Biotech, has said the Chinese firm is in talks about creating a Covid-19 vaccine production site in Africa, as it launches a phase-three trial for use in children.
On Friday, Hilton Klein, the CEO of Numolux Group, said that Sinovac Biotech was eying the creation of a production site in South Africa for the production of Covid-19 vaccines and more.
Continue reading https://on.rt.com/bgf3